FDA: GLP-1 inhibitors Diabetes Drugs Not Linked to Pancreatic Cancer

In yet another boost to several large drugmakers, the FDA has agreed with European regulators there is no existing evidence to confirm recent concerns that a widely used group of diabetes drugs called GLP-1 inhibitors is linked to pancreatic cancer, an FDA spokeswoman says.

Read more

Posted in Drugs Medical Research